Quick Answer
KalVista Pharmaceuticals, Inc. reported Total Revenue of $12.69 million for fiscal year 2020.
KalVista Pharmaceuticals, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2020 | $12.69M | -21.3% |
| 2019 | $16.13M | +92.1% |
| 2018 | $8.39M | +458.1% |
| 2017 | $1.50M | -29.5% |
| 2016 | $2.13M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.69M | — | +860.2% |
| July 31, 2025 | $1.43M | — | -9.6% |
| January 31, 2020 | $1.58M | -59.5% | -59.8% |
| October 31, 2019 | $3.92M | -29.9% | +16.4% |
| July 31, 2019 | $3.37M | -9.4% | -13.4% |
| January 31, 2019 | $3.89M | +66.9% | -30.4% |
| October 31, 2018 | $5.59M | +396.2% | +50.4% |
| July 31, 2018 | $3.72M | +3772.9% | +59.5% |
- KalVista Pharmaceuticals, Inc. showed a decrease of -21.3% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2020 period, KalVista Pharmaceuticals, Inc.’s total revenue has grown by 494.9% (from $2.13 million to $12.69 million).
- The most recent figure is from KalVista Pharmaceuticals, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on July 7, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: